1. Home
  2. ELTK vs ESLA Comparison

ELTK vs ESLA Comparison

Compare ELTK & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eltek Ltd.

ELTK

Eltek Ltd.

HOLD

Current Price

$8.31

Market Cap

53.3M

Sector

Technology

ML Signal

HOLD

Logo Estrella Immunopharma Inc.

ESLA

Estrella Immunopharma Inc.

HOLD

Current Price

$1.80

Market Cap

60.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELTK
ESLA
Founded
1970
2021
Country
Israel
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.3M
60.9M
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
ELTK
ESLA
Price
$8.31
$1.80
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$8.00
AVG Volume (30 Days)
3.7K
177.7K
Earning Date
05-19-2026
05-26-2026
Dividend Yield
2.28%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.18
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$48.71
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.73
$0.78
52 Week High
$12.19
$3.15

Technical Indicators

Market Signals
Indicator
ELTK
ESLA
Relative Strength Index (RSI) 46.25 68.48
Support Level $7.79 $1.41
Resistance Level $9.34 $2.18
Average True Range (ATR) 0.37 0.24
MACD 0.03 0.04
Stochastic Oscillator 54.89 77.06

Price Performance

Historical Comparison
ELTK
ESLA

About ELTK Eltek Ltd.

Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. The company manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnect, flex-rigid and multi-layered boards. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. The geographic areas of the company are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.

About ESLA Estrella Immunopharma Inc.

Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.

Share on Social Networks: